| Company/Division name | Uvax Bio |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 63 |
| Year reshoring announced: | 2022 |
| City reshored to: | Newark |
| State(s) reshored to: | DE |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | COVID-19 and HIV-1 vaccine |
| What domestic positive factors made reshoring more attractive? | Government Incentives, Manufacturing/engineering joint innovation (R&D), Skilled workforce availability/training, Under-utilized capacity |
